BioSpace News Archive

Drug Development

LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

LIXTE Biotechnology Holdings, Inc announces that Professor René Bernards, Netherlands Cancer Institute (NKI), Amsterdam, presented new data from promising drug combinations of LIXTE’s lead clinical cancer compound, LB-100, at the Annual Meeting of American Association for Cancer Research.

April 12, 2022
·
4 min read
Business

SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF DR. JANE F. BARLOW TO THE SERA PROGNOSTICS BOARD

Sera Prognostics Inc. today announced that Dr. Jane F. Barlow has joined the Sera Board of Directors.

April 12, 2022
·
6 min read
Deals

Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Kintara Therapeutics, Inc. today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 16,226,416 shares of the Company’s common stock.

April 12, 2022
·
5 min read
FDA

Blue Earth Therapeutics Announces U.S. FDA Clearance for Investigational New Drug (IND) Application for 177Lu-rhPSMA-10.1 for Treatment of Prostate Cancer

Blue Earth Therapeutics Announces U.S. FDA Clearance for Investigational New Drug (IND) Application for 177 Lu-rhPSMA-10.1 for Treatment of Prostate Cancer.

April 12, 2022
·
5 min read
Biotech Beach

Progenity to Become Biora Therapeutics as it Completes Transformation

Progenity, Inc. announced that it will change its name to Biora Therapeutics, Inc. during the second quarter of 2022, to better reflect the company’s focus on developing its pipeline for targeted and systemic oral delivery of biotherapeutics.

April 12, 2022
·
1 min read
BioMidwest

Leader in Oxygen Sensing Solutions Launches RAD-0002-ZR Oxygen Deficiency Alarm for Low Temperatures to Exceed Current Standards

Gaslab® Inc., a leader in gas sensing technologies and safety solutions, has released the new RAD-0002-ZR Oxygen Deficiency Alarm designed to measure potentially dangerous oxygen levels in low temperature applications.

April 12, 2022
·
3 min read
Drug Development

Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting

Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) targeting technologies, is pleased to announce the Company’s poster presentation at the AACR Annual Meeting.

April 12, 2022
·
5 min read
Pathios Therapeutics Highlights Role of GPR65 as Critical Innate Immune Checkpoint in the Human Tumor Microenvironment and Reports Anti-Tumor Activity of GPR65 Inhibition During Podium Presentation at AACR 2022

Pathios Therapeutics Limited (“Pathios”), a biotech company focused on the development of first-in-class therapies for cancer, today announced that new data on PTT-3213.

April 12, 2022
·
4 min read
Drug Development

Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting

Schrödinger, Inc. today presented new preclinical data from its Wee1 inhibitor program in a poster session at the American Association of Cancer Research (AACR) Annual Meeting taking place in New Orleans.

April 12, 2022
·
6 min read
Pharm Country

Osmol Therapeutics Announces Closing of Series A-1 Funding to Advance the Clinical Development of the First Therapy to Prevent Chemotherapy-Induced Neuropathy

Osmol Therapeutics today announced that it has closed the first $5.2 million tranche of a $7.5 million Series A-1 financing led by Koax Investment Partners.

April 12, 2022
·
3 min read